What Happened? Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, ...

According to Benzinga Pro, Abbott Laboratories's peer group average for short interest as a percentage of float is 5.57%, ...

IBM posts strong Q3 results as Watsonx and quantum bets boost growth, while Micron rides AI-driven memory demand and Abbott expands on device strength.

Analysts expect the North Chicago, Illinois-based company to report quarterly earnings at $1.30 per share, up from $1.21 per ...

Abbott trimmed its earnings forecast as the Trump administration launched an investigation into medical device imports that could trigger new tariffs.

The stock's fall snapped a two-day winning streak.

Abbott ABT has consistently demonstrated strong growth and gained market share within its Nutrition business. Its Diabetes Care business continues to benefit from the growing sales of its flagship, ...

That being said, even among dividend stocks, many aren't worth sticking with for the long term. Let's consider one dividend payer that is: Abbott Laboratories ( ABT +0.40%). This healthcare leader has ...

Benchmark anticipates that Abbott’s Diagnostics business will pick up speed again in 2026 with the introduction of a new ...

This was the stock's second consecutive day of losses.